(Q36371635)

English

S0502: A SWOG Phase III Randomized Study of Imatinib, With or Without Bevacizumab, in Patients With Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors

scientific article

Statements

S0502: A SWOG Phase III Randomized Study of Imatinib, With or Without Bevacizumab, in Patients With Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors (English)
17 November 2015

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit